Optimized Synthesis and Spectral Characterization of Some Hydrazones Based on 5-Nitroindazole with Pharmacological Potential

Authors

  • C. Cheptea “Gr. T. Popa” University of Medicine and Pharmacy, Faculty of Medical Bioengineering
  • L. M. Ivan ”Al. I. Cuza” University, Faculty of Physics
  • D. O. Dorohoi ”Al. I. Cuza” University, Faculty of Physics
  • V. Sunel “Al. I. Cuza” University, Faculty of Chemistry
  • I. Hurjui “Gr. T. Popa” University of Medicine and Pharmacy, Faculty of Medicine
  • C. I. Saveanu “Gr. T. Popa” University of Medicine and Pharmacy, Faculty of Dental Medicine
  • A. I. Galaction “Gr. T. Popa” University of Medicine and Pharmacy, Faculty of Medical Bioengineering

DOI:

https://doi.org/10.15407/ujpe59.03.0313

Keywords:

Hydrazones, HyperChem, antitumor effect

Abstract

A number of new hydrazones with biological activity are synthesized on the basis of 5-nitroindazole. The most efficient conditions of their synthesis with maximum reaction yield are established. The chemical structure of new compounds is found by the elemental analysis, FTIR spectroscopy, and 1H-NMR method. The data of spectral analysis were verified by calculations with the HyperChem software. Toxicological tests indicate that the synthesized hydrazones have the antitumor effect.

References

J.-H. Sun, C.A. Teleha, J.-S. Yan, J.D. Rodgers, and D.A. Nugiel, J. Org. Chem. 62, 5627 (1997).

https://doi.org/10.1021/jo970375b

J.D. Rodgers, B.L. Johnson, H. Wang, R.A. Greenberg, S. Erickson-Viitanen, R.M. Klabe, B.C. Cordova, M.M. Rayner, G.N. Lam, and C.-H. Chang, Bioorg. Med. Chem. Lett. 6, 2919 (1996).

https://doi.org/10.1016/S0960-894X(96)00531-8

M.H. Norman, F. Navas, J.B. Thompson, G.C. Rigdon, J. Med. Chem. 39, 4692 (1996).

https://doi.org/10.1021/jm9603375

T. Yoshida, N. Matsuura, K. Yamamoto, M. Doi, K. Shimada, T. Morie, and S. Kato, Heterocycles 43, 2701 (1996).

https://doi.org/10.3987/COM-96-7614

D.W. Robertson, W. Bloomquist, M.L. Cohen, L.R. Reid, K. Schenck, and D.T. Wong, J. Med. Chem. 33, 3176 (1990).

https://doi.org/10.1021/jm00174a013

B.K. Keppler and M. Hartmann, Met. Based Drugs 1, 145 (1994).

https://doi.org/10.1155/MBD.1994.145

X. Li, S. Chu, V.A. Feher, M. Khalili, Z. Nie, S. Margosiak, V. Nikulin, J. Levin, K.G. Sprankle, M.E. Tedder, R. Almassy, K. Appelt, and K.M. Yager, J. Med. Chem. 46, 5663 (2003).

https://doi.org/10.1021/jm0302039

J. Rodriguez, A. Gerpe, G. Aguirre, U. Kemmerling, O. Piro, V. Ar’an, J. Maya, C.O. Azar, M. Gonz’ales, and H. Cerecetto, Eur. J. Med. Chem. 44, 1545 (2009).

https://doi.org/10.1016/j.ejmech.2008.07.018

L. Bouissoine, S. Kazzouli, L. Pfeiffer, E.M. Rakis, M. Khouili, and G. Guillaumet, Bioorg. Med. Chem. 14, 1078 (2006).

https://doi.org/10.1016/j.bmc.2005.09.037

Wei Li, Yan Lu, Z. Wang, J.T. Dalton, and D.D. Miller, Bioorg. Med. Chem. Lett. 17, 4113 (2007).

https://doi.org/10.1016/j.bmcl.2007.05.059

T. Yakaian, V.P. Lingaiah, B. Naraian, B. Shidhar, Bioorg. Med. Chem. 17, 3445 (2007).

https://doi.org/10.1016/j.bmcl.2007.03.087

L.J. Huang, M.L. Shih, H.S. Chen, S.L. Pan, C.M. Teng, F.Y. Lee, and S.C. Kuo, Bioorg Med. Chem. 14, 528 (2006).

https://doi.org/10.1016/j.bmc.2005.08.032

M. Ribeira, J. Cabral, and A. Cimas, J. Chem. Thermodyn. 42, 1240 (2010).

https://doi.org/10.1016/j.jct.2010.04.026

A. Gerpe, G. Aguirre, L. Boiani, H. Cerecetto, M. Gonz’ales, C.O. Azar, C. Riogol, J. Maya, A. Morello, O. Piro, V. Ar’an, A. Azqueta, A. Cer’ain, A. Monge, A. M. Rojas, and G. Yalluf, Bioorg. Med. Chem. 14, 3467 (2006).

https://doi.org/10.1016/j.bmc.2006.01.007

M. Alho, N. R. Sanchez, N.J. Ruiz, A.J. Escario, G.A. Barrio, R.A. Fernandez, and V. Aran, J. Med. Chem. 4, 78 (2009).

C. Cheptea, V. Sunel, L. Profire, M. Popa, and C. Lionte, Bul. Inst. Polit. Iasi 55, 85 (2009).

M.A. Hamilton, R.C. Russo, and R.V. Thurston, Envir. Sci. Techn. 12, 417 1978.

https://doi.org/10.1021/es60140a017

A. Azzouz, M. Leontie, D.O. Dorohoi, and C. Gheorghies, Elemente de Strategie in Design Industrial (Plumb, Bacau, 1998).

L. Fisher, Design for Environment, Creating Eco-Efficient Products and Processes (McGraw Hill, New York, 1996).

I. Hurjui, C. Cheptea, CF. Dascalu, L. Hurjui, C. Peptu, V. Sunel, and D.O. Dorohoi, Dig. J. Nanomater. Biostr. 7, 1747 (2012).

M. Moise, V. Sunel, M.M. Dulcescu, and D.O. Dorohoi, Rev. de Chim. 61, 799 (2010).

UJP 2014 V59 #3

Downloads

Published

2018-10-19

How to Cite

Cheptea, C., Ivan, L. M., Dorohoi, D. O., Sunel, V., Hurjui, I., Saveanu, C. I., & Galaction, A. I. (2018). Optimized Synthesis and Spectral Characterization of Some Hydrazones Based on 5-Nitroindazole with Pharmacological Potential. Ukrainian Journal of Physics, 59(3), 313. https://doi.org/10.15407/ujpe59.03.0313

Issue

Vol. 59 No. 3 (2014)

Section

Solid matter

License

Copyright Agreement
License to Publish the Paper
Kyiv, Ukraine

The corresponding author and the co-authors (hereon referred to as the Author(s)) of the paper being submitted to the Ukrainian Journal of Physics (hereon referred to as the Paper) from one side and the Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, represented by its Director (hereon referred to as the Publisher) from the other side have come to the following Agreement:

1. Subject of the Agreement.
The Author(s) grant(s) the Publisher the free non-exclusive right to use the Paper (of scientific, technical, or any other content) according to the terms and conditions defined by this Agreement.

2. The ways of using the Paper.
2.1. The Author(s) grant(s) the Publisher the right to use the Paper as follows.
2.1.1. To publish the Paper in the Ukrainian Journal of Physics (hereon referred to as the Journal) in original language and translated into English (the copy of the Paper approved by the Author(s) and the Publisher and accepted for publication is a constitutive part of this License Agreement).
2.1.2. To edit, adapt, and correct the Paper by approval of the Author(s).
2.1.3. To translate the Paper in the case when the Paper is written in a language different from that adopted in the Journal.
2.2. If the Author(s) has(ve) an intent to use the Paper in any other way, e.g., to publish the translated version of the Paper (except for the case defined by Section 2.1.3 of this Agreement), to post the full Paper or any its part on the web, to publish the Paper in any other editions, to include the Paper or any its part in other collections, anthologies, encyclopaedias, etc., the Author(s) should get a written permission from the Publisher.

3. License territory.
The Author(s) grant(s) the Publisher the right to use the Paper as regulated by sections 2.1.1–2.1.3 of this Agreement on the territory of Ukraine and to distribute the Paper as indispensable part of the Journal on the territory of Ukraine and other countries by means of subscription, sales, and free transfer to a third party.

4. Duration.
4.1. This Agreement is valid starting from the date of signature and acts for the entire period of the existence of the Journal.

5. Loyalty.
5.1. The Author(s) warrant(s) the Publisher that:
– he/she is the true author (co-author) of the Paper;
– copyright on the Paper was not transferred to any other party;
– the Paper has never been published before and will not be published in any other media before it is published by the Publisher (see also section 2.2);
– the Author(s) do(es) not violate any intellectual property right of other parties. If the Paper includes some materials of other parties, except for citations whose length is regulated by the scientific, informational, or critical character of the Paper, the use of such materials is in compliance with the regulations of the international law and the law of Ukraine.

6. Requisites and signatures of the Parties.
Publisher: Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine.
Address: Ukraine, Kyiv, Metrolohichna Str. 14-b.
Author: Electronic signature on behalf and with endorsement of all co-authors.

Crossref
Scopus
Google Scholar
Europe PMC